oncgnostics GmbH
Develops IVD tests for screening;therapeutic decision making;and follow-up care in cancer diagnostics
oncgnostics GmbH has raised €1.0M across 2 funding rounds from 2 investors, most recently a round in Sep 2023. Based in Germany; founded 2012; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€1.0M
€1,000,000
Funding rounds
2
Investors
2
distinct backers
Active since
2017-02
latest 2023-09
Funding by year
EUR raised per yearoncgnostics GmbH — funding by year — interactive chart.
Data table
| oncgnostics GmbH — funding by year | |
|---|---|
| 2017 | €1.0M |
| 2023 | €0 |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
- ▼ Low backer re-investment
Exit likelihood5
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-09-11 | Other | — | Grande Bio-tech Co. | View deal → |
| 2017-02-01 | Early VC | €1.0M | bm-t Beteiligungsmanagement Thüringen GmbH | View deal → |
Related news
Similar companies
same sector or country- Delivery Hero€7.1BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Helsing€2.9BGermany · AI
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
Global coverage: FundingData